Personalised treatment for pancreatic cancer
Pancreatic cancer is the third leading cause of cancer related death, and is predicted to be the second within a decade. The overall five-year survival is less than 5%, one of the lowest among all cancer types, and this survival rate has not changed for more than 50 years. Recent large scale genomic studies demonstrated vast inter-tumoural heterogeneity, which may have contributed to the challenges in therapeutic development. In this talk, the key results of recent genomic studies will be presented, and novel therapeutic strategies using a personalised approach will be discussed.

References: Biankin et al, Nature 2012; Waddell et al, Nature 2015; Biankin et al, Nature 2015; Bailey et al, Nature 2016
Date: 4 August 2016, 17:00 (Thursday, 15th week, Trinity 2016)
Venue: Old Road Campus
Venue Details: Ludwig Seminar Room, Old Road Campus Research Building
Speaker: Dr David Chang (University of Glasgow)
Organising department: Nuffield Department of Surgical Sciences
Organiser: Dr Regent Lee (University of Oxford )
Organiser contact email address: regent.lee@nds.ox.ac.uk
Topics:
Booking required?: Not required
Audience: Members of the University only
Editor: Louise King